Concepedia

Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study

Irene van der Horst‐Bruinsma, Rianne E. van Bentum, Frank D. Verbraak, Atul Deodhar, Bengt Hoepken, Oscar Irvin-Sellers, Karen Thomas, Lars Bauer, Martín Rudwaleit

Therapeutic Advances in Musculoskeletal Disease · 2021 · 22 citations · 18 references

Open access

Abstract

NCT03020992, URL: https://clinicaltrials.gov/ct2/show/NCT03020992.

References

18

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

Martín Rudwaleit, Désirée van der Heijde, R. B. M. Landewé et al. · Annals of the Rheumatic Diseases · 2009 · 3.5K citations · Full text

The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort

Martín Rudwaleit, Hildrun Haibel, Xenofon Baraliakos et al. · Arthritis & Rheumatism · 2009 · 713 citations

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Robert Landewé, Jürgen Braun, Atul Deodhar et al. · Annals of the Rheumatic Diseases · 2013 · 462 citations · Full text

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study

Martín Rudwaleit, E Rødevand, Peter Holck et al. · Annals of the Rheumatic Diseases · 2008 · 284 citations · Full text

Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study

Sandra Guignard, Laure Gossec, Carine Salliot et al. · Annals of the Rheumatic Diseases · 2006 · 224 citations · Full text